EDGAR Filing Documents for 0001279569-14-000164

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-14-000164

Filing Date

2014-02-11

Accepted

2014-02-11 12:58:41

Documents

Period of Report

2013-11-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	12830
2	PRESS RELEASE DATED JANUARY 7, 2014	ex991.htm	EX-99.1	35985
3	Q2 INTERIM FIANANCIAL STATEMENTS	ex992.htm	EX-99.2	290912
4	Q2 MANAGEMENTS DISCUSSION AND ANALYSIS	ex993.htm	EX-99.3	160498
5	CEO/CFO CERTIFICATES	ex994.htm	EX-99.4	18118
6	LOGO	image_001.jpg	GRAPHIC	4372
	Complete submission text file	0001279569-14-000164.txt		525728

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 14592763
SIC: 2836 Biological Products, (No Diagnostic Substances)